Open Access · CC BY-NC 4.0
Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention
Cardiovascular Prevention and Pharmacotherapy · 2019
DOI: 10.36011/cpp.2019.1.e1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Prevention and Pharmacotherapy, 2019. Verfasst von Jang-Whan Bae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bae, J. (2019). Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. https://doi.org/10.36011/cpp.2019.1.e1
Vancouver
Bae J. Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. 2019. doi:10.36011/cpp.2019.1.e1
BibTeX
@article{Bae2019,
author = {Bae, Jang-Whan},
title = {Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention},
journal = {Cardiovascular Prevention and Pharmacotherapy},
year = {2019},
doi = {10.36011/cpp.2019.1.e1}
}
EUVIMED